関連する実験動画
Updated: Sep 9, 2025

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
347
リウマチ性関節炎における非従来のT細胞の役割を探る
Tangqing Xu1, Hao Cai1, Jianye Liu1
1Department of Orthopedics, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu, China.
Frontiers in immunology
|September 5, 2025
まとめ
NKT,MAIT, γδ T細胞を含む非伝統的なT細胞は,関節リウマチ (RA) の病原性において重要な役割を果たします. これらの細胞をターゲットにすることで RAの治療に 新しい治療戦略が期待できます
科学分野:
- 免疫学
- リウマトロジ
- 自己免疫性
背景:
- リウマチ性関節炎 (RA) は,関節の炎症と破壊によって特徴づけられる慢性的な自己免疫疾患です.
- 従来のT細胞は伝統的に関与していますが,従来とは異なるT細胞のサブセットが注目されています.
研究 の 目的:
- RAにおける非従来のT細胞サブセットの免疫学的特性と病原性役割の包括的な検討
- これらの細胞を標的とした 新しい治療戦略を強調する
主な方法:
- RAにおける自然キラーT細胞,粘膜関連インヴァリアントT細胞,ガンマデルタT細胞に焦点を当てた文献レビュー.
- 単細胞オミクスと空間免疫プロファイルの最近の進歩の分析
主要な成果:
- 非従来のT細胞は,先天性免疫と適応性免疫の間の橋渡しとなり,サイトカイン生成とサイト毒性によってRAに寄与する.
- これらの細胞は 独特の組織トロピズムを持つ 多様なプラスチックメカニズムを通じて 炎症と関節破壊を拡大します
結論:
- 非従来のT細胞は RAの病原性において重要な役割を果たし,潜在的治療標的を提供している.
- 先進的なプロファイリング技術は,パーソナライズされた免疫療法のための正確な特徴付けを可能にします.
関連する概念動画
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
230
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
230
Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K
T Cell Activation and Clonal Selection
4.4K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
4.4K
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
264
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
264

